Suchergebnisse für «»
| von Willebrand-Faktor und Faktor VIII in Kombination (B02BD06) | Contenuto | Cat | PR | AD | Prezzo p.u. | |
|---|---|---|---|---|---|---|
HAEMATE P Trockensub 250/600 IE c Solv+Set
CSL Behring AG • Trockensubstanz |
1 Stk | B | 308.40 CHF | 308.40 CHF | ||
HAEMATE P Trockensub 500/1200 IE c Solv+Set
CSL Behring AG • Trockensubstanz |
1 Stk | B | 509.55 CHF | 509.55 CHF | ||
HAEMATE P Trockensub 1000/2400 IE c Solv+Set
CSL Behring AG • Trockensubstanz |
1 Stk | B | 978.15 CHF | 978.15 CHF | ||
Blutgerinnungsfaktor XIII (B02BD07) |
||||||
FIBROGAMMIN Trockensub 250 IE c Solv Transfer Set (250 IE)
CSL Behring AG • Trockensubstanz |
1 Stk | B | 216.15 CHF | 216.15 CHF | ||
FIBROGAMMIN Trockensub 1250 IE c Solv Transfer Set (1250 IE)
CSL Behring AG • Trockensubstanz |
1 Stk | B | 916.85 CHF | 916.85 CHF | ||
Blutgerinnungsfaktor VIIa (B02BD08) |
||||||
NovoSeven® Raumtemperaturstabiles Injektionspräparat (1 mg)
Novo Nordisk Pharma AG • Trockensubstanz |
1 Stk | B | 907.55 CHF | 907.55 CHF | ||
NovoSeven® Raumtemperaturstabiles Injektionspräparat (2 mg)
Novo Nordisk Pharma AG • Trockensubstanz |
1 Stk | B | 1774.15 CHF | 1774.15 CHF | ||
NovoSeven® Raumtemperaturstabiles Injektionspräparat (5 mg)
Novo Nordisk Pharma AG • Trockensubstanz |
1 Stk | B | 4370.80 CHF | 4370.80 CHF | ||
von Willebrand-Faktor (B02BD10) |
||||||
WILLFACT Trockensub 1000 IE c Solv (10ml) (1000 IE)
Opopharma Vertriebs AG • Injektionslösung |
1 Stk | B | 810.05 CHF | 810.05 CHF | ||
VEYVONDI Trockensub 650 IE c Solv (650 IE)
Takeda Pharma AG • Trockensubstanz |
1 Stk | B | 587.15 CHF | 587.15 CHF | ||
VEYVONDI Trockensub 1300 IE c Solv (1300 IE)
Takeda Pharma AG • Trockensubstanz |
1 Stk | B | 1133.30 CHF | 1133.30 CHF | ||
Susoctocog alfa (B02BD14) |
||||||
OBIZUR Trockensub 500 E c Solv (500 E)
Takeda Pharma AG • Trockensubstanz |
1 Stk | B | k.a. | k.a. | ||
OBIZUR Trockensub 500 E c Solv (500 E)
Takeda Pharma AG • Trockensubstanz |
5 Stk | B | k.a. | k.a. | ||
Etamsylat (B02BX01) |
||||||
DICYNONE Inj Lös 250 mg (250 mg)
OM Pharma SA • Injektionslösung |
4x2 ml | B | 9.35 CHF | 4.67 CHF | ||
DICYNONE® 500 Kapseln (500 mg)
OM Pharma SA • Kapseln |
20 Stk | B | k.a. | k.a. | ||
Romiplostim (B02BX04) |
||||||
NPLATE Trockensub 250 mcg c Solv (250 mcg)
Amgen Switzerland AG • Trockensubstanz |
1 Stk | A | 716.55 CHF | 716.55 CHF | ||
NPLATE Trockensub 500 mcg c Solv (500 mcg)
Amgen Switzerland AG • Trockensubstanz |
1 Stk | A | 1399.30 CHF | 1399.30 CHF | ||
Eltrombopag (B02BX05) |
||||||
Revolade® Filmtabletten (25 mg)
Novartis Pharma Schweiz AG • Filmtabletten |
14 Stk | A | 711.05 CHF | 50.79 CHF | ||
Revolade® Filmtabletten (25 mg)
Novartis Pharma Schweiz AG • Filmtabletten |
28 Stk | A | 1388.75 CHF | 49.60 CHF | ||
Revolade® Filmtabletten (50 mg)
Novartis Pharma Schweiz AG • Filmtabletten |
14 Stk | A | 1388.75 CHF | 99.20 CHF | ||
Revolade® Filmtabletten (50 mg)
Novartis Pharma Schweiz AG • Filmtabletten |
28 Stk | A | 2716.00 CHF | 97.00 CHF | ||
Revolade® Filmtabletten (12.5 mg)
Novartis Pharma Schweiz AG • Filmtabletten |
14 Stk | A | 363.75 CHF | 25.98 CHF | ||
Revolade® Filmtabletten (75 mg)
Novartis Pharma Schweiz AG • Filmtabletten |
28 Stk | A | 3967.25 CHF | 141.69 CHF | ||
Emicizumab (B02BX06) |
||||||
Hemlibra® (30 mg/ml)
Roche Pharma (Schweiz) AG • Injektionslösung |
1 Stk | A | 2036.40 CHF | 2036.40 CHF | ||
Hemlibra® (60 mg/0.)
Roche Pharma (Schweiz) AG • Injektionslösung |
1 Stk | A | 4031.75 CHF | 4031.75 CHF | ||
Hemlibra® (105 mg/0.)
Roche Pharma (Schweiz) AG • Injektionslösung |
1 Stk | A | 7024.85 CHF | 7024.85 CHF | ||
Hemlibra® (150 mg/ml)
Roche Pharma (Schweiz) AG • Injektionslösung |
1 Stk | A | 10017.90 CHF | 10017.90 CHF | ||
Avatrombopag (B02BX08) |
||||||
DOPTELET Filmtabl 20 mg (20 mg)
Swedish Orphan Biovitrum AG • Filmtabletten |
10 Stk | A | 886.55 CHF | 88.66 CHF | ||
DOPTELET Filmtabl 20 mg (20 mg)
Swedish Orphan Biovitrum AG • Filmtabletten |
30 Stk | A | 2555.35 CHF | 85.18 CHF | ||
DOPTELET Filmtabl 20 mg (20 mg)
Swedish Orphan Biovitrum AG • Filmtabletten |
15 Stk | A | 1308.45 CHF | 87.23 CHF | ||
Eisen-II-glycin-sulfat-Komplex (B03AA01) |
||||||
ferro sanol® (100 mg)
UCB-Pharma SA • Retardkapseln |
50 Stk | D | 12.65 CHF | 0.25 CHF | ||
Eisen-II-fumarat (B03AA02) |
||||||
Ferrum Hausmann® (100 mg)
Vifor (International) Inc. • Retardkapseln |
100 Stk | D | 24.30 CHF | 0.24 CHF | ||
Ferrum Hausmann® (100 mg)
Vifor (International) Inc. • Retardkapseln |
30 Stk | D | 8.60 CHF | 0.29 CHF | ||
Eisen-II-sulfat (B03AA07) |
||||||
Aktiferrin Tropfen zum Einnehmen, Lösung
Mepha Pharma AG • Tropfen |
30 ml | D | k.a. | k.a. | ||
Ferro-Gradumet®
Farmaceutica Teofarma Suisse SA • Retardtabletten |
30 Stk | D | k.a. | k.a. | ||
Ferro-Gradumet®
Farmaceutica Teofarma Suisse SA • Retardtabletten |
90 Stk | D | k.a. | k.a. | ||
Tardyferon® (80 mg)
Pierre Fabre Pharma AG • Retardtabletten |
30 Stk | D | 8.45 CHF | 0.28 CHF | ||
Tardyferon® (80 mg)
Pierre Fabre Pharma AG • Retardtabletten |
100 Stk | D | 25.50 CHF | 0.26 CHF | ||
Eisen-III-hydroxid-Polymaltose Komplex (B03AB05) |
||||||
Maltofer® Sirup
Vifor (International) Inc. • Sirup |
150 ml | D | 11.05 CHF | 0.07 CHF | ||
Maltofer® Tropfen zum Einnehmen
Vifor (International) Inc. • Tropfen |
30 ml | D | 9.20 CHF | 0.31 CHF | ||
Fonte dati: 
Aggiornamento dati del 17.10.2023 • Copyright © 2012-2023 HMG GmbH • mymedi.ch • Tutti i diritti riservati
Programmazione e Design: Hayloft-IT GmbH
La piattaforma di ricerca di medicamenti mymedi® è gestita da HMG GmbH HealthCare Management Group, che è responsabile sia dei contenuti pubblicati sia del trattamento dei dati.